Ferring Pharmaceuticals Inc.
Ferring Pharmaceuticals Inc., a global biopharmaceutical company, is headquartered in the United States and operates extensively across Europe, Asia, and Latin America. Founded in 1950, Ferring has established itself as a leader in reproductive health, urology, and gastroenterology, focusing on innovative therapies that address unmet medical needs.
The company is renowned for its core products, including hormone therapies and treatments for various gastrointestinal disorders, which are distinguished by their patient-centric approach and commitment to research and development. Ferring's dedication to advancing healthcare has positioned it as a notable player in the biopharmaceutical industry, with significant achievements in clinical research and a robust pipeline of therapies aimed at improving patient outcomes.
+27 vs industry average
Ferring Pharmaceuticals Inc.’s score of 66 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ferring Pharmaceuticals Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Ferring Pharmaceuticals Inc. yet.
Ferring Pharmaceuticals Inc.'s reported carbon emissions
Ferring Pharmaceuticals Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Ferring Holding SA, which may influence its climate commitments and reporting practices.
Ferring Pharmaceuticals has not established specific reduction targets or initiatives, as there are no documented SBTi (Science Based Targets initiative) or CDP (Carbon Disclosure Project) reduction targets available. This lack of data suggests that the company may still be in the early stages of developing its climate strategy.
As a subsidiary, Ferring Pharmaceuticals may align its climate commitments with those of its parent company, Ferring Holding SA. However, without specific emissions data or reduction targets, it is challenging to assess the company's current impact on climate change or its future commitments.
In summary, Ferring Pharmaceuticals Inc. has not disclosed any carbon emissions data or specific climate commitments, reflecting a potential area for development in their sustainability strategy.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Ferring Pharmaceuticals Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Ferring Pharmaceuticals Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Ferring Holding SA
Carbon Disclosure Project
Inherited from Ferring Holding SAThe Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Ferring Pharmaceuticals Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project